Suppr超能文献

在日本,乙型肝炎病毒和丙型肝炎病毒的双重感染在肝细胞癌的发病机制中是否起重要作用?

Does dual infection by hepatitis B and C viruses play an important role in the pathogenesis of hepatocellular carcinoma in Japan?

作者信息

Shiratori Y, Shiina S, Zhang P Y, Ohno E, Okudaira T, Payawal D A, Ono-Nita S K, Imamura M, Kato N, Omata M

机构信息

Department of Internal Medicine (II), University of Tokyo, Japan.

出版信息

Cancer. 1997 Dec 1;80(11):2060-7.

PMID:9392327
Abstract

BACKGROUND

There are contradictory data concerning the synergistic effect of hepatitis B virus (HBV) and hepatitis C virus (HCV) infection on the progression from chronic hepatitis to hepatocellular carcinoma (HCC).

METHODS

To clarify the role of coinfection with HBV and HCV in the progression and pathogenesis of HCC, viral and clinicopathologic features were studied in 368 consecutive HCC patients at the University of Tokyo from 1991-1995.

RESULTS

Approximately 83% of patients (305 patients) were seropositive for the HCV antibody ("C-viral") and approximately 10% (37 patients) were positive for the hepatitis B surface antigen ("B-viral"). Positivity for both (dual infection) was found in only 2% of patients, and negativity for both in 5%. The incidence of dual infection in HCC patients was Similar to that in 549 patients with chronic hepatitis (1%) and 119 patients with cirrhosis (1%). Of the six HCC patients with dual infection, five patients were positive for the HBV early antigen and HBV DNA was less than measurable, whereas HCV RNA was detected and ranged from 10(3)-10(6) copies/50 microL of serum by competitive reverse transcriptase-polymerase chain reaction, and the clinical features resembled those of "C-viral" HCC. The remaining patient was early antigen positive and had HBV DNA by slot blot analysis, but the serum HCV RNA level was less than measurable. These data indicate that mutually exclusive viral replication occurred in patients with persistent coinfection. To further clarify further the possible involvement of HBV infection in "C-viral" HCC, HBV core antibody (HBcAb) was tested in 192 patients and was found to be positive in 111 and negative in 81. The serum HCV RNA level and clinicopathologic features (such as age and the severity of liver disease) were similar among the "C-viral" HCC patients irrespective of the presence or absence of HBcAb.

CONCLUSIONS

Based on these results, coinfection was found to be much less prevalent than generally is claimed, and even in a few HCC patients with the coinfection the mutually exclusive viral replication was noted, suggesting that coinfection plays little if any role in the development of HCC.

摘要

背景

关于乙型肝炎病毒(HBV)和丙型肝炎病毒(HCV)感染对从慢性肝炎进展为肝细胞癌(HCC)的协同作用,存在相互矛盾的数据。

方法

为阐明HBV和HCV合并感染在HCC进展和发病机制中的作用,对1991年至1995年东京大学连续收治的368例HCC患者的病毒学和临床病理特征进行了研究。

结果

约83%的患者(305例)HCV抗体血清学阳性(“C病毒感染”),约10%(37例)乙型肝炎表面抗原阳性(“B病毒感染”)。两者均阳性(双重感染)的患者仅占2%,两者均阴性的占5%。HCC患者中双重感染的发生率与549例慢性肝炎患者(1%)和119例肝硬化患者(1%)相似。在6例双重感染的HCC患者中,5例HBV早期抗原阳性且HBV DNA低于可检测水平,而通过竞争性逆转录聚合酶链反应检测到HCV RNA,血清中HCV RNA水平为10³-10⁶拷贝/50微升,其临床特征与“C病毒感染”的HCC相似。其余1例患者早期抗原阳性,经斑点杂交分析有HBV DNA,但血清HCV RNA水平低于可检测水平。这些数据表明,持续性双重感染患者中病毒复制相互排斥。为进一步阐明HBV感染在“C病毒感染”的HCC中可能的作用,对192例患者检测了HBV核心抗体(HBcAb),其中111例阳性,81例阴性。“C病毒感染”的HCC患者中,无论有无HBcAb,血清HCV RNA水平和临床病理特征(如年龄和肝病严重程度)相似。

结论

基于这些结果,发现双重感染的发生率远低于普遍认为的水平,即使在少数双重感染的HCC患者中也观察到病毒复制相互排斥,这表明双重感染在HCC发生过程中即便有作用也很小。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验